Clinical Microbiology Reviews· 2022Q1· Review
Updated Review on<i>Nocardia</i>Species: 2006–2021
- 162citations
- Q1SCImago
- 2022year
Short summary
This review updates the understanding of Nocardia species, incorporating taxonomic changes and the impact of new technologies like MALDI-TOF and whole genome sequencing on diagnosis and treatment.
AI-generated from the title and abstract; the full text is not read.
Key points
- Significant taxonomic expansion of the Nocardia genus since 2006.
- New technologies like MALDI-TOF and whole genome sequencing are transforming Nocardia diagnosis.
- Updated insights into clinical manifestations, epidemiology, and geographic distribution.
- Includes a new section on actinomycotic mycetoma.
AI-generated from the title and abstract; the full text is not read.
Abstract
review by Brown-Elliott et al. published in 2006 (B. A. Brown-Elliott, J. M. Brown, P. S. Conville, and R. J. Wallace. Jr., Clin Microbiol Rev 19:259-282, 2006, https://doi.org/10.1128/CMR.19.2.259-282.2006). Included is a discussion on the taxonomic expansion of the genus, current identification methods, and the impact of new technology (including matrix-assisted laser desorption ionization-time of flight [MALDI-TOF] and whole genome sequencing) on diagnosis and treatment. Clinical manifestations, the epidemiology, and geographic distribution are briefly discussed. An additional section on actinomycotic mycetoma is added to address this often-neglected disease.
The authors' abstract, as published at the source. Clinical Microbiology Reviews, 2022 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Microbiology
MicrobiologyMedicine